NIM811 (N-methyl-4-isoleucine cyclosporine), a mitochondrial permeability transition inhibitor, attenuates cholestatic liver injury but not fibrosis in mice.
Cholestasis causes hepatocyte death, possibly because of mitochondrial injury. This study investigated whether NIM811 (N-methyl-4-isoleucine cyclosporine), an inhibitor of the mitochondrial permeability transition (MPT), attenuates cholestatic liver injury in vivo. Cholestasis was induced in mice by bile duct ligation (BDL). NIM811 was gavaged (20 mg/kg) before BDL and daily (10 mg/kg) afterward. Mitochondrial depolarization, cell death, and MPT onset were assessed by intravital confocal/multiphoton microscopy of rhodamine 123, propidium iodide, and calcein. After BDL, serum alanine aminotransferase (ALT), hepatic necrosis, and apoptosis all increased. NIM811 decreased ALT, necrosis, and apoptosis by 60 to 86%. In vehicle-treated mice at 6 h after BDL, viable hepatocytes with depolarized mitochondria were 18/high-power field (hpf), and nonviable cells were approximately 1/hpf, showing that depolarization preceded necrosis. Calcein entered mitochondria after BDL, indicating MPT onset in vivo. NIM811 decreased depolarization by 72%, prevented calcein entry into mitochondria, and blocked release of cytochrome c. Hepatic tumor necrosis factor alpha, transforming growth factor-beta1, procollagen alpha1(I) mRNA, alpha-smooth muscle actin, and Sirius red staining for collagen increased after BDL but were not different in vehicle- and NIM811-treated mice. Taken together, NIM811 decreased cholestatic necrosis and apoptosis but did not block fibrosis, indicating that the MPT plays an important role in cholestatic cell death in vivo.
Rehman
Hasibur
H
Department of Pharmaceutical and Biomedical, Sciences, Medical University of South Carolina, Charleston, SC 29425, USA.
Ramshesh
Venkat K
VK
Theruvath
Tom P
TP
Kim
Insil
I
Currin
Robert T
RT
Giri
Shailendra
S
Lemasters
John J
JJ
Zhong
Zhi
Z
D000818:Animals; D016923:Cell Death / Q000187:drug effects; D002779:Cholestasis / Q000188:drug therapy*; D003094:Collagen / Q000032:analysis; D016572:Cyclosporine / Q000494:pharmacology*; D005355:Fibrosis; D022781:Hepatocytes / Q000378:metabolism / Q000648:ultrastructure; D008564:Membrane Potentials / Q000187:drug effects; D051379:Mice; D051336:Mitochondrial Membranes / Q000502:physiology*; D010539:Permeability / Q000187:drug effects
D016572:Cyclosporine; D003094:Collagen; C090438:(melle-4)cyclosporin
Biochem J. 1995 Apr 1;307 ( Pt 1):99-106
7718000
J Gastroenterol Hepatol. 2007 Jun;22 Suppl 1:S79-84
17567474
Liver Int. 2007 Nov;27(9):1273-81
17919240
J Hepatol. 2000;32(1 Suppl):129-40
10728800
Hepatology. 2001 Mar;33(3):616-26
11230742
Free Radic Biol Med. 2000 Jan 15;28(2):251-60
11281292
Nat Rev Mol Cell Biol. 2001 Jan;2(1):63-7
11413467
FEBS Lett. 2002 Feb 13;512(1-3):1-7
11852041
Gene Ther. 2002 Feb;9(3):183-91
11859421
J Investig Med. 2002 May;50(3):193-200
12033284
Mol Pharmacol. 2002 Jul;62(1):22-9
12065751
Dig Liver Dis. 2002 Jun;34(6):387-92
12132783
Biochim Biophys Acta. 2003 Jan 20;1637(1):127-32
12527417
Lab Invest. 2003 May;83(5):655-63
12746475
Curr Med Chem. 2003 Aug;10(16):1507-25
12871123
Gastroenterology. 2003 Sep;125(3):854-67
12949730
Curr Mol Med. 2003 Sep;3(6):527-35
14527084
Am J Physiol Gastrointest Liver Physiol. 2003 Nov;285(5):G1004-13
12791596
Nature. 2004 Jan 29;427(6973):461-5
14749836
Hepatology. 2004 Oct;40(4):998-1007
15382126
Biochim Biophys Acta. 1986 Jul 23;850(3):436-48
2873836
Biochem J. 1990 May 15;268(1):153-60
2160810
Hepatology. 2008 Jan;47(1):236-46
18023036
Physiol Rev. 2008 Jan;88(1):125-72
18195085
Gastroenterology. 1995 Oct;109(4):1249-56
7557092
J Exp Med. 1996 Apr 1;183(4):1533-44
8666911
Biochem J. 1996 Jun 15;316 ( Pt 3):765-9
8670150
Free Radic Biol Med. 1996;20(3):351-9
8720905
J Hepatol. 1997 Aug;27(2):363-70
9288612
Biochim Biophys Acta. 1998 Aug 10;1366(1-2):167-75
9714791
J Clin Invest. 1999 Jan;103(1):137-45
9884343
Semin Liver Dis. 1999;19(2):129-40
10422196
J Hepatol. 2005 Mar;42(3):378-85
15710221
Nature. 2005 Mar 31;434(7033):658-62
15800627
Gastroenterology. 2005 Jul;129(1):351-60
16012960
J Pediatr Gastroenterol Nutr. 2005 Aug;41(2):235-43
16056106
Gut. 2006 Jan;55(1):90-7
16041064
Drug Metab Dispos. 2006 Sep;34(9):1575-81
16760228
Chem Biol Interact. 2006 Oct 27;163(1-2):145-59
16889760
J Gastroenterol. 2006 Oct;41(10):971-80
17096066
Am J Transplant. 2007 May;7(5):1103-11
17456198
Arch Biochem Biophys. 2007 Jun 15;462(2):124-31
17258167
J Gastroenterol Hepatol. 2007 Jun;22 Suppl 1:S73-8
17567473